论文信息 - Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations - 字舞流文

Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations

J. Baselga | G. Gupta | C. Chung | N. Lee | I. Ganly | D. Higginson | S. Powell | M. Scaltriti | Z. Zumsteg | L. Morris | N. Morse | G. Krigsfeld | S. Shiao